Form 4: Cooper Companies Director Robert Weiss Exercises Stock Options and Sells Shares

Robert Weiss, a director at Cooper Companies, exercised stock options and sold shares on March 7th and 8th, 2024, according to a Form 4 filing with the SEC.

Summary

• Robert Weiss, a director of Cooper Companies, executed transactions involving the company's stock on March 7th and 8th, 2024.
• Weiss exercised stock options to acquire 153,213 shares on March 7th and 88,075 shares on March 8th at a price of $57.415 per share.
• Concurrently, Weiss sold 153,213 shares on March 7th at a weighted average price of $102.2081 and 88,075 shares on March 8th at a weighted average price of $102.1826.
• The sales were executed in multiple transactions with prices ranging from $101.89 to $102.8125 on March 7th and from $101.87 to $102.515 on March 8th.
• Following these transactions, Weiss directly owns 282,772 shares of Cooper Companies common stock.
• Weiss also indirectly owns 295,360 shares through the Robert S. Weiss and Marilyn A. Weiss Trust dated May 17, 2006.
• The stock options exercised were granted under a plan with an exercise price of $57.415 and an expiration date of December 12, 2027.
• The reported transactions reflect adjustments for the Issuer's 4-for-1 stock split effected on February 16, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating routine insider transactions. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Option exercises followed by sales are a common way for executives to monetize their compensation.

Comparison to Industry Standards

• It's common for executives at publicly traded companies like Cooper Companies to receive stock options as part of their compensation packages.
• The exercise of these options and subsequent sale of shares is a typical wealth management strategy.
• The timing and size of these transactions are often scrutinized by investors to gauge executive sentiment, although they are often pre-planned under 10b5-1 trading plans.
• Comparable companies in the healthcare or medical device sectors, such as Alcon or Bausch + Lomb, also see similar patterns of insider trading activity.

Stakeholder Impact

• The transactions could have a minor impact on shareholders due to the increased supply of shares in the market.
• The director's actions may be interpreted by the market as a signal, though the impact is likely to be minimal given the routine nature of option exercises and sales.

Key Dates